Stigma Grow Adds High-Potency Pre-Rolls to their Growing Portfolio of In-Demand Cannabis Products

May 26, 2020

In a market saturated with unattractive pre-rolls made with mid-potency and blended shake — high-potency, bud-run pre-rolls have a very bright future.

Red Deer, May 26 , 2020  – CanadaBis Capital Inc. (“CanadaBis” or “the Company”), a vertically integrated Canadian cannabis company focused on finding and capitalizing on growth and diversification opportunities, is pleased to announce that its subsidiary Stigma Grow, has recently received multiple POs across Canada for their Craft Cannon and Craft Cannon Plus; potent cannabis pre-rolls boasting first-run percentages of 24.3 and 28.2% THC respectively.

Stigma Grow, whose mission and mandate revolve around crushing the negative stigmas that surround both cannabis as a beneficial plant and the legal cannabis market as an effective provider, recognizes an unmet need for craft-cultivated, high-potency pre-rolls, and is perfectly positioned as a cultivator and third-party processor to fulfill it.

Stigma Grow: Craft Cannabis

On May 15th, the Company oversaw the shipment of Stigma Grow’s first 35K pre-rolled joints. Currently, Stigma Grow has Purchase Orders (POs) in place that respond to a specific need for Alberta-grown, high-potency products, and is in the midst of securing POs across Canada to satisfy similar requests for craft-quality, potent pre-rolls.

Our approach to securing and maintaining high-quality is simple.”, says Travis McIntyre, President and CEO of Stigma Grow. “We hand-pick only the best buds for our pre-rolled joints; either from our facility in Red Deer Alberta, or from one of the many local quality LPs throughout our province and across the country. Leveraging this approach, we’re able to meet the growing demand for the convenience and consistency of high-potency, bud-run pre-rolls, right across Canada. We already know that the future of cannabis is strong – and obviously, we aim to please.”

Over the past few months, after years of strategic growth, responsible investing and due diligence in market research, Stigma Grow has emerged as an LP with their finger on the pulse of a cannabis market itching for the next best thing in cannabis.

As first-to-market in Canada for BHO Live Resin and Cured concentrates, and a current in-demand processor of brand name and third-party processed products, their unique skillset is on display early for a customer base whose appetite for attractive and available legal cannabis products remains unsatisfied.

Travis explains, “Our vision as a company has always been to provide our community with what is in-demand, and all signs point to the need for consistent, high-potency, bud-run products. Thanks to our top-quality flower, state-of-the-art technology and unique expertise, we’ve experienced an increase in momentum over the past few months that has positioned our company for the type of growth and influence we’ve always envisioned.”

About CanadaBis Capital Inc.

CanadaBis Capital Inc. (TSXV:CANB) is a vertically integrated Canadian cannabis company focused on achieving large-scale growth in the fast-emerging global cannabis market. By targeting organic growth opportunities alongside the right-fit partners, we remain focused on finding and capitalizing on chances to grow, diversify and continue to lead our industry.

For more information on CanadaBis Capital, Stigma Grow, or INDICAtive Collection please visit www.canadabis.com, www.stigmagrow.ca, www.indicativecollection.ca or contact:

Investor Relations

Info@CanadaBis.com

1-888-STIGMA1

Back to Press Releases